BAUSCH + LOMB CORP (BLCO:NYSE)
$16.49 -0.17 (-1.0204%)
Analysed BAUSCH + LOMB CORP (BLCO:NYSE) News Sources
Bausch + Lomb (BLCO) Stock Trades Below Fair Value As Caution Lingers
29-08-2026
yahoo.com
Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds
01-09-2026
yahoo.com
Bausch + Lomb Announces European CE Mark Approval of SeeLyra™ Femtosecond Laser
11-09-2026
yahoo.com
Robinson Pharma, Inc. Receives "Above and Beyond" Supplier Award from Bausch + Lomb for September 2026
16-09-2026
yahoo.com
Bausch + Lomb Will Release Third-Quarter 2026 Financial Results on Oct. 28
05-10-2026
yahoo.com
3 Low-Volatility Stocks with Open Questions
08-10-2026
yahoo.com
Bausch + Lomb's Dry Eye Disease Prescription Momentum Builds, Forex Turns as Modest Headwind in Q3, RBC Says
08-10-2026
yahoo.com
Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance
12-10-2026
yahoo.com
Bausch + Lomb swaps CEOs; Merck reveals anticipated eye drug data
12-10-2026
biopharmadive.com
3 Reasons BLCO is Risky and 1 Stock to Buy Instead
16-10-2026
yahoo.com
What is the current price of BAUSCH + LOMB CORP (BLCO:NYSE)?
The current price of BAUSCH + LOMB CORP (BLCO:NYSE) is $16.49.
BAUSCH + LOMB CORP (BLCO:NYSE) absolute price change since previous trading day?
The absolute price change of BAUSCH + LOMB CORP (BLCO:NYSE) since the previous trading day is $-0.17.
BAUSCH + LOMB CORP (BLCO:NYSE) percentage price change since previous trading day?
The percentage price change of BAUSCH + LOMB CORP (BLCO:NYSE) since the previous trading day is -1.0204%.
What is the most recent average sentiment score for BAUSCH + LOMB CORP (BLCO:NYSE)?
The most recent average sentiment score for BAUSCH + LOMB CORP (BLCO:NYSE) is 50 out of 100.
What is the most recent average sentiment for BAUSCH + LOMB CORP (BLCO:NYSE)?
The most recent sentiment for BAUSCH + LOMB CORP (BLCO:NYSE) is .
SEC-8K** Filing Available For BAUSCH + LOMB CORP (BLCO:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.